RTNTF
RIO TINTO LTD
$128.00
0.00%
No data for this timeframe.
Vol
SEC Reports4
Recent Activity
Jun 1, 2026
SEC
Rio Tinto published its Report on Payments to Governments for FY2025, disclosing total payments of US$6.28 billion in ta
6-K — Impact 2/10
May 14, 2026
SEC
Rio Tinto announced the appointment of Trudi Charles as its new Chief Legal Officer, Governance & Corporate Affairs, eff
6-K — Impact 2/10
May 1, 2026
SEC
Rio Tinto's April 2026 6-K filing bundles routine administrative updates: final 2025 dividend of $2.54 per share paid, D
6-K — Impact 2/10
Analyst Ratings
2Strong Buy
8Buy
9Hold
0Sell
0Strong Sell
Latest Reports
NEUTRAL
6-K
2/10
Rio Tinto published its Report on Payments to Governments for FY2025, disclosing total payments of US$6.28 billion in ta
Jun 1, 2026
NEUTRAL
6-K
2/10
Rio Tinto announced the appointment of Trudi Charles as its new Chief Legal Officer, Governance & Corporate Affairs, eff
May 14, 2026
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
4 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 4 neutral. Avg impact: 2.0/10.
NEUTRAL
6-K
2/10
Rio Tinto published its Report on Payments to Governments for FY2025, disclosing total payments of U
Jun 1, 2026
NEUTRAL
6-K
2/10
Rio Tinto announced the appointment of Trudi Charles as its new Chief Legal Officer, Governance & Co
May 14, 2026
NEUTRAL
6-K
2/10
Rio Tinto's April 2026 6-K filing bundles routine administrative updates: final 2025 dividend of $2.
May 1, 2026
NEUTRAL
6-K
2/10
The 6-K filing primarily consists of a Form 604 notice disclosing changes in substantial holdings of
Apr 1, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 53% buy across 19 analysts — 2 strong buy, 8 buy, 9 hold, 0 sell, 0 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $63.7B | 10.5% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $65.1B | 2.3% | — |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 8 | 9 | 0 | 0 | 53% | |
| May 1, 2026 | 3 | 7 | 8 | 0 | 0 | 56% | |
| Apr 1, 2026 | 3 | 7 | 8 | 0 | 0 | 56% | |
| Mar 1, 2026 | 3 | 6 | 8 | 1 | 0 | 50% | |
| Feb 1, 2026 | 3 | 5 | 6 | 1 | 0 | 53% | |
| Jan 1, 2026 | 3 | 8 | 7 | 1 | 0 | 58% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.